Reuters logo
BRIEF-VBI Vaccines says to present new preclinical data for its GBM Immunotherapy, VBI-1901, at Immuno-Oncology Summit​
August 28, 2017 / 12:46 PM / 2 months ago

BRIEF-VBI Vaccines says to present new preclinical data for its GBM Immunotherapy, VBI-1901, at Immuno-Oncology Summit​

Aug 28 (Reuters) - VBI Vaccines Inc:

* Says ‍VBI vaccines to present new preclinical data for its GBM immunotherapy, VBI-1901, at Immuno-Oncology Summit​

* VBI Vaccines - ‍expects to initiate enrollment in multi-center phase i/2a clinical study evaluating vbi-1901 in patients with recurrent GBM in H2 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below